The WHO explained the suspension of vaccination with the drug AstraZeneca

The World Health Organization (WHO) explained the suspension of the use of the vaccine from the British-Swedish company AstraZeneca in several European countries. This is reported by RIA Novosti with reference to the Deputy Director General of the WHO, Mariangela Simao.

According to her, the organization considered these actions by the authorities of European states as a precautionary measure. Simao stressed that WHO is now working with the European Medicines Agency and national regulators to assess all incoming data on vaccines and their side effects.

Earlier, Spain, Germany, France and Italy stopped vaccination against coronavirus with the drug AstraZeneca. The authorities came to such a decision after reports of poor health among those who received the vaccine.

At the same time, the company announced the safety of the vaccine. AstraZeneca explained that a detailed study of the health status of more than 17 million people vaccinated in the EU and the UK with the coronavirus drug showed no data on an increased risk of pulmonary embolism, deep vein thrombosis or thrombocytopenia.

However, nine more European countries have stopped or temporarily limited vaccination with AstraZeneca due to thrombosis in their vaccinated patients. Austria, Estonia, Latvia, Lithuania and Luxembourg have stopped using the drug from a specific batch of one million doses, which was supplied to 17 European countries. At the same time, Denmark, Iceland and Norway have stopped all their supplies of this vaccine.

Vladimir Kuznetsov

Сообщение The WHO explained the suspension of vaccination with the drug AstraZeneca появились сначала на supercar.ru.